Market Overview

Teva Announces Signing of New $3B Syndicated Revolving Credit Line

Share:
Related TEVA
7 Stocks Which Plummeted Three Days On Increasing Volume
Mike Khouw Sees Unusual Options Activity In Teva Pharmaceutical
Amgen Migraine Drug Likely To Beat Eli Lilly, Alder, Teva To Market (Investor's Business Daily)

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new five-year, $3.0 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.

Posted-In: News Financing

 

Related Articles (TEVA)

View Comments and Join the Discussion!